Related Experiment Video

Updated: Jun 18, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Glycemic control and cardiovascular events in diabetic hemodialysis patients

Christiane Drechsler1, Vera Krane, Eberhard Ritz

  • 1Department of Medicine, Division of Nephrology, University Hospital, Oberdürrbacherstrasse 6, D-97080 Würzburg, Germany. c.drechsler@gmx.net

Circulation
|December 2, 2009
PubMed

Insights

Poor glycemic control significantly increases sudden cardiac death risk in diabetic hemodialysis patients. This heightened risk contributes to overall cardiovascular events and mortality, underscoring the need for better blood sugar management.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Background:

  • Patients on maintenance dialysis face high mortality, primarily from sudden cardiac death.
  • Poor glycemic control is a known risk factor for cardiovascular disease in the general population.
  • This study examines the link between glycemic control and cardiac/vascular outcomes in diabetic hemodialysis patients.

Purpose of the Study:

  • To investigate the impact of glycemic control on cardiac and vascular outcomes.
  • To assess the association between HbA1c levels and specific adverse events in diabetic hemodialysis patients.
  • To determine if poor glycemic control predicts sudden cardiac death, myocardial infarction, stroke, or all-cause mortality.

Main Methods:

  • The German Diabetes and Dialysis Study (4D Study) included 1255 diabetic hemodialysis patients.
  • Glycohemoglobin A1c (HbA1c) was measured at baseline.
  • Cox regression analyses were used to determine hazard ratios for predefined endpoints over a median follow-up of 4 years.

Main Results:

  • Patients with HbA1c >8% had over double the risk of sudden cardiac death compared to those with HbA1c ≤6%.
  • Each 1% increase in HbA1c was associated with an 18% rise in sudden death risk and an 8% rise in cardiovascular events and mortality.
  • Myocardial infarction risk was not significantly affected, but trends suggested higher risks for stroke and heart failure deaths.

Conclusions:

  • Poor glycemic control is strongly linked to sudden cardiac death in diabetic hemodialysis patients.
  • Sudden cardiac death, driven by poor glycemic control, accounts for increased cardiovascular events and mortality.
  • Further research is needed to determine if intensive glycemic control reduces sudden cardiac death in this population.
Abstract

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...